Research on atrial fibrillation diagnosis in electrocardiograms based on CLA-AF model

基于CLA-AF模型的心电图房颤诊断研究

阅读:3

Abstract

AIMS: The electrocardiogram (ECG) is the primary method for diagnosing atrial fibrillation (AF), but interpreting ECGs can be time-consuming and labour-intensive, which deserves more exploration. METHODS AND RESULTS: We collected ECG data from 6590 patients as YY2023, classified as Normal, AF, and Other. Convolutional Neural Network (CNN), bidirectional Long Short-Term Memory (BiLSTM), and Attention construct the AF recognition model CNN BiLSTM Attention-Atrial Fibrillation (CLA-AF). The generalization ability of the model is validated on public datasets CPSC2018, PhysioNet2017, and PTB-XL, and we explored the performance of oversampling, resampling, and hybrid datasets. Finally, additional PhysioNet2021 was added to validate the robustness and applicability in different clinical settings. We employed the SHapley Additive exPlanations (SHAP) method to interpret the model's predictions. The F1-score, Precision, and area under the ROC curve (AUC) of the CLA-AF model on YY2023 are 0.956, 0.970, and 1.00, respectively. Similarly, the AUC on CPSC2018, PhysioNet2017, and PTB-XL reached above 0.95, demonstrating its strong generalization ability. After oversampling PhysioNet2017, F1-score and Recall improved by 0.156 and 0.260. Generalization ability varied with sampling frequency. The model trained from the hybrid dataset has the most robust generalization ability, achieving an AUC of 0.96 or more. The AUC of PhysioNet2021 is 1.00, which proves the applicability of CLA-AF. The SHAP values visualization results demonstrate that the model's interpretation of AF aligns with the diagnostic criteria of AF. CONCLUSION: The CLA-AF model demonstrates a high accuracy in recognizing AF from ECG, exhibiting remarkable applicability and robustness in diverse clinical settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。